Androstanediol glucuronide in patients with pancreatic cancer and in those with chronic pancreatitis

Hormone and Metabolic Research

Volumn 28, Issue 8, 1996, Pages 381-383

  Jansa R ^a   Prezelj J ^a   Kocijancic, A ^a   Osredkar, J ^a   Ferlic, F ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Androgens; Androstanediol glucuronide; Chronic pancreatitis; Pancreatic cancer

Indexed keywords

ANDROSTANOLONE; ANDROSTENEDIONE; CA 19-9 ANTIGEN; PRASTERONE SULFATE; TESTOSTERONE;

ADULT; AGED; ANDROGEN METABOLISM; ARTICLE; BLOOD ANALYSIS; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MALE; PANCREAS CANCER; PRIORITY JOURNAL;

EID: 0029764613     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979820     Document Type: Article

References (12)

1. Deslypere, J. P., A. Sayed, U. Punjabi, L. Verdonck, A. Vermeulen: Plasma 5α-androstane-3α, 17β-diol and urinary 5α-androstane-3α, 17β-diol glucuronide, parameters of peripheral androgen action: a comparative study. J. Clin. Endocrinol. Metab. 54: 386-391 (1982)
2. Fabris, C., G. Del Favero, D. Basso, A. Piccoli, T. Meggiato, C. Angonesse, M. Plebani, G. Leandro, A. Burlina, R. Naccarato: Serum markers and clinical data in diagnosing pancreatic cancer: a contrastive approach. Am. J. Gastroenterol. 83: 549-535 (1988)
3. Gray, A., H. A. Feldman, B. McKinlay, C. Longcope: Age, disease and changing sex hormone levels in middle-aged men: results of Massachusetts male aging study. J. Clin. Endocrinol. Metab. 73: 1016-1025 (1991)
4. Greenway, B., M. J. Iqbal, P. J. Johnson, R. William: Low testosterone concentrations in patients with carcinoma of the pancreas. Brit. Med. J. 286: 93-95 (1983)
5. Iqbal, M. J., B. Greenway, M. L. Wilkinson, P. J. Johnson, R. Williams: Sex-steroid enzymes, aromatase and 5-alfa reductase in the pancreas: a comparison of normal adult, foetal and malignant tissue. Clin. Sci. 65: 71-75 (1983)
6. Moghissi, E., F. Ablan, R. Horton: Origin of plasma androstanediol glucuronide in men. J. Clin. Endocrinol. Metab. 59: 417-421 (1984)
7. Nahoul, K., M. Roger: Age-related decline of plasma bioavailable testosterone in adult men. J. Steroid. Biochem. 35: 293-299 (1990)
8. Robles-Diaz, G., V. Diaz-Sanchez, J. P. Mendez, A. Altamirano, E. Wolpert: Low serum testosterone/dihydrotestosterone ratio in patients with pancreatic carcinoma. Pancreas 2: 684-687 (1987)
9. Schmiegel, W.: Tumor markers in pancreatic cancer - current concepts. Hepato-gastroenterol. 36: 446-449 (1989)
10. Sperti, C., B. Bonadimani, C. Militello, F. Capallazzo, S. Pedrazzolli: Testosteron and androgen metabolism in pancreatic cancer. Lett. to the edit. J. Clin. Gastroenterol. 15: 161-162 (1992)
11. Todd, B. D.: Pancreatic carcinoma and low serum testosterone; a correlation secondary to cancer cachexia? Eur. J. Surg. Oncol. 14: 199-202 (1988)
12. Tulassay, Z., Z. Sandor, L. Bodrogi, J. Papp, T. Feher: An endocrine marker for pancreatic cancer. Brit. Med. J. 297: 1447-1448 (1988)